Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News

Table of Contents

Editor's Note

  • Editor's Note
    Introducing CCR Focus
    Susan E. Bates
    Clin Cancer Res September 15 2006 12 (18) 5255-5255; DOI:10.1158/1078-0432.CCR-06-2125

Editorial

  • Editorial
    The Impact of Genetics on Sarcoma Diagnosis: An Evolving Science
    Frederic G. Barr and Paul J. Zhang
    Clin Cancer Res September 15 2006 12 (18) 5256-5257; DOI:10.1158/1078-0432.CCR-06-1321

  • Editorial
    Challenges of Chemosensitivity Testing
    Patrick Hwu, Agop Y. Bedikian and Elizabeth A. Grimm
    Clin Cancer Res September 15 2006 12 (18) 5258-5259; DOI:10.1158/1078-0432.CCR-06-1656

The Biology Behind

  • The Biology Behind
    Tumor Hypoxia Imaging
    Inna Serganova, John Humm, Clifton Ling and Ronald Blasberg
    Clin Cancer Res September 15 2006 12 (18) 5260-5264; DOI:10.1158/1078-0432.CCR-06-0517

  • The Biology Behind
    Studying Human Regulatory T Cells In vivo
    Emmanuel Zorn and Jerome Ritz
    Clin Cancer Res September 15 2006 12 (18) 5265-5267; DOI:10.1158/1078-0432.CCR-06-1417

Molecular Pathways

  • Molecular Pathways
    The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy
    Maurizio Scaltriti and José Baselga
    Clin Cancer Res September 15 2006 12 (18) 5268-5272; DOI:10.1158/1078-0432.CCR-05-1554

CCR Focus

  • CCR Focus
    From the Editor
    Susan E. Bates
    Clin Cancer Res September 15 2006 12 (18) 5273-5273; DOI:10.1158/1078-0432.CCR-12-18-INT

  • CCR Focus
    A New Generation of Mouse Models of Cancer for Translational Research
    Cory Abate-Shen
    Clin Cancer Res September 15 2006 12 (18) 5274-5276; DOI:10.1158/1078-0432.CCR-06-0500

  • CCR Focus
    The Use of Targeted Mouse Models for Preclinical Testing of Novel Cancer Therapeutics
    Kenneth P. Olive and David A. Tuveson
    Clin Cancer Res September 15 2006 12 (18) 5277-5287; DOI:10.1158/1078-0432.CCR-06-0436

  • CCR Focus
    Mouse Models of Brain Tumors and Their Applications in Preclinical Trials
    Elena I. Fomchenko and Eric C. Holland
    Clin Cancer Res September 15 2006 12 (18) 5288-5297; DOI:10.1158/1078-0432.CCR-06-0438

  • CCR Focus
    A Mouse Model System to Genetically Dissect the Molecular Mechanisms Regulating Tumorigenesis
    Kurt Degenhardt and Eileen White
    Clin Cancer Res September 15 2006 12 (18) 5296-5304; DOI:10.1158/1078-0432.CCR-06-0439

  • CCR Focus
    Mouse Modeling in Oncologic Preclinical and Translational Research
    Brett S. Carver and Pier P. Pandolfi
    Clin Cancer Res September 15 2006 12 (18) 5305-5311; DOI:10.1158/1078-0432.CCR-06-0482

  • CCR Focus
    Using Genetically Engineered Mouse Models of Cancer to Aid Drug Development: An Industry Perspective
    Mallika Singh and Leisa Johnson
    Clin Cancer Res September 15 2006 12 (18) 5312-5328; DOI:10.1158/1078-0432.CCR-06-0437

Report from the FDA

  • Report from the FDA
    Approval Summary: Nelarabine for the Treatment of T-Cell Lymphoblastic Leukemia/Lymphoma
    Martin H. Cohen, John R. Johnson, Tristan Massie, Rajeshwari Sridhara, W. David McGuinn Jr., Sophia Abraham, Brian P. Booth, M. Anwar Goheer, David Morse, Xiao H. Chen, Nallaperumal Chidambaram, Leslie Kenna, Jogarao V. Gobburu, Robert Justice and Richard Pazdur
    Clin Cancer Res September 15 2006 12 (18) 5329-5335; DOI:10.1158/1078-0432.CCR-06-0606

Review

  • Review
    Protein Kinase C as a Therapeutic Target
    Beverly A. Teicher
    Clin Cancer Res September 15 2006 12 (18) 5336-5345; DOI:10.1158/1078-0432.CCR-06-0945

Human Cancer Biology

  • Human Cancer Biology
    Curcumin Inhibits Neurotensin-Mediated Interleukin-8 Production and Migration of HCT116 Human Colon Cancer Cells
    Xiaofu Wang, Qingding Wang, Kirk L. Ives and B. Mark Evers
    Clin Cancer Res September 15 2006 12 (18) 5346-5355; DOI:10.1158/1078-0432.CCR-06-0968

  • Human Cancer Biology
    EWS-CREB1: A Recurrent Variant Fusion in Clear Cell Sarcoma—Association with Gastrointestinal Location and Absence of Melanocytic Differentiation
    Cristina R. Antonescu, Khedoudja Nafa, Neil H. Segal, Paola Dal Cin and Marc Ladanyi
    Clin Cancer Res September 15 2006 12 (18) 5356-5362; DOI:10.1158/1078-0432.CCR-05-2811

  • Human Cancer Biology
    Overexpression of Cyclase-Associated Protein 2 in Multistage Hepatocarcinogenesis
    Rie Shibata, Taisuke Mori, Wenlin Du, Makoto Chuma, Masahiro Gotoh, Motohide Shimazu, Masakazu Ueda, Setsuo Hirohashi and Michiie Sakamoto
    Clin Cancer Res September 15 2006 12 (18) 5363-5368; DOI:10.1158/1078-0432.CCR-05-2245

  • Human Cancer Biology
    Twist Overexpression Correlates with Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal Transition
    Terence K. Lee, Ronnie T.P. Poon, Anthony P. Yuen, Ming Tat Ling, Wei Kei Kwok, Xiang Hong Wang, Yong Chuan Wong, Xin Yuan Guan, Kwan Man, King Lok Chau and Sheung Tat Fan
    Clin Cancer Res September 15 2006 12 (18) 5369-5376; DOI:10.1158/1078-0432.CCR-05-2722

  • Human Cancer Biology
    Clonal Origin of Metastatic Testicular Teratomas
    Timothy D. Jones, Mingsheng Wang, Ming-Tse Sung, Shaobo Zhang, Thomas M. Ulbright, John N. Eble, Stephen D. Beck, Richard S. Foster, John J. Anagnostou Jr., Clay Conner and Liang Cheng
    Clin Cancer Res September 15 2006 12 (18) 5377-5383; DOI:10.1158/1078-0432.CCR-06-0444

  • Human Cancer Biology
    Novel Thioredoxin Inhibitors Paradoxically Increase Hypoxia-Inducible Factor-α Expression but Decrease Functional Transcriptional Activity, DNA Binding, and Degradation
    Dylan T. Jones, Christopher W. Pugh, Simon Wigfield, Malcolm F.G. Stevens and Adrian L. Harris
    Clin Cancer Res September 15 2006 12 (18) 5384-5394; DOI:10.1158/1078-0432.CCR-05-2380

  • Human Cancer Biology
    Snail and Slug Play Distinct Roles during Breast Carcinoma Progression
    Christophe Côme, Fabrice Magnino, Frédéric Bibeau, Pascal De Santa Barbara, Karl Friedrich Becker, Charles Theillet and Pierre Savagner
    Clin Cancer Res September 15 2006 12 (18) 5395-5402; DOI:10.1158/1078-0432.CCR-06-0478

  • Human Cancer Biology
    HATH1 Expression in Mucinous Cancers of the Colorectum and Related Lesions
    Eun Taek Park, Hee Kyung Oh, James R. Gum Jr., Suzanne C. Crawley, Sanjay Kakar, Juan Engel, Ching Ching Leow, Wei-Qiang Gao and Young S. Kim
    Clin Cancer Res September 15 2006 12 (18) 5403-5410; DOI:10.1158/1078-0432.CCR-06-0573

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    S100P Is an Early Developmental Marker of Pancreatic Carcinogenesis
    Kenoki Ohuchida, Kazuhiro Mizumoto, Takuya Egami, Hiroshi Yamaguchi, Kei Fujii, Hiroyuki Konomi, Eishi Nagai, Koji Yamaguchi, Masazumi Tsuneyoshi and Masao Tanaka
    Clin Cancer Res September 15 2006 12 (18) 5411-5416; DOI:10.1158/1078-0432.CCR-06-0298

  • Imaging, Diagnosis, Prognosis
    S100A11, A Putative Tumor Suppressor Gene, Is Overexpressed in Pancreatic Carcinogenesis
    Kenoki Ohuchida, Kazuhiro Mizumoto, Seiji Ohhashi, Hiroshi Yamaguchi, Hiroyuki Konomi, Eishi Nagai, Koji Yamaguchi, Masazumi Tsuneyoshi and Masao Tanaka
    Clin Cancer Res September 15 2006 12 (18) 5417-5422; DOI:10.1158/1078-0432.CCR-06-0222

  • Imaging, Diagnosis, Prognosis
    Prevalence of FOXP3+ Regulatory T Cells Increases During the Progression of Pancreatic Ductal Adenocarcinoma and Its Premalignant Lesions
    Nobuyoshi Hiraoka, Kaoru Onozato, Tomoo Kosuge and Setsuo Hirohashi
    Clin Cancer Res September 15 2006 12 (18) 5423-5434; DOI:10.1158/1078-0432.CCR-06-0369

  • Imaging, Diagnosis, Prognosis
    Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer
    Joseph G. Rajendran, David L. Schwartz, Janet O'Sullivan, Lanell M. Peterson, Patrick Ng, Jeffrey Scharnhorst, John R. Grierson and Kenneth A. Krohn
    Clin Cancer Res September 15 2006 12 (18) 5435-5441; DOI:10.1158/1078-0432.CCR-05-1773

  • Imaging, Diagnosis, Prognosis
    Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma
    Padmanee Sharma, Yu Shen, Sijin Wen, Dean F. Bajorin, Victor E. Reuter, Lloyd J. Old and Achim A. Jungbluth
    Clin Cancer Res September 15 2006 12 (18) 5442-5447; DOI:10.1158/1078-0432.CCR-06-0527

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Matrix Metalloproteinase Polymorphisms and Survival in Stage I Non–Small Cell Lung Cancer
    Rebecca Suk Heist, Ariela L. Marshall, Geoffrey Liu, Wei Zhou, Li Su, Donna Neuberg, Thomas J. Lynch, John Wain and David C. Christiani
    Clin Cancer Res September 15 2006 12 (18) 5448-5453; DOI:10.1158/1078-0432.CCR-06-0262

  • Cancer Therapy: Clinical
    In vitro Drug Sensitivity Predicts Response and Survival after Individualized Sensitivity-Directed Chemotherapy in Metastatic Melanoma: A Multicenter Phase II Trial of the Dermatologic Cooperative Oncology Group
    Selma Ugurel, Dirk Schadendorf, Claudia Pföhler, Karsten Neuber, Adina Thoelke, Jens Ulrich, Axel Hauschild, Konstanze Spieth, Martin Kaatz, Werner Rittgen, Stefan Delorme, Wolfgang Tilgen and Uwe Reinhold
    Clin Cancer Res September 15 2006 12 (18) 5454-5463; DOI:10.1158/1078-0432.CCR-05-2763

  • Cancer Therapy: Clinical
    Photofrin Uptake in the Tumor and Normal Tissues of Patients Receiving Intraperitoneal Photodynamic Therapy
    Stephen M. Hahn, Mary E. Putt, James Metz, Daniel B. Shin, Elizabeth Rickter, Chandrakala Menon, Debbie Smith, Eli Glatstein, Douglas L. Fraker and Theresa M. Busch
    Clin Cancer Res September 15 2006 12 (18) 5464-5470; DOI:10.1158/1078-0432.CCR-06-0953

  • Cancer Therapy: Clinical
    A Phase I Biological and Pharmacologic Study of the Heparanase Inhibitor PI-88 in Patients with Advanced Solid Tumors
    Michele Basche, Daniel L. Gustafson, Scott N. Holden, Cindy L. O'Bryant, Lia Gore, Samir Witta, Mary Kay Schultz, Mark Morrow, Adrah Levin, Brian R. Creese, Michael Kangas, Kaye Roberts, Thu Nguyen, Kat Davis, Russell S. Addison, Jane C. Moore and S. Gail Eckhardt
    Clin Cancer Res September 15 2006 12 (18) 5471-5480; DOI:10.1158/1078-0432.CCR-05-2423

  • Cancer Therapy: Clinical
    Population Pharmacokinetic-Pharmacodynamic Model for Neutropenia with Patient Subgroup Identification: Comparison across Anticancer Drugs
    Charlotte Kloft, Johan Wallin, Anja Henningsson, Etienne Chatelut and Mats O. Karlsson
    Clin Cancer Res September 15 2006 12 (18) 5481-5490; DOI:10.1158/1078-0432.CCR-06-0815

  • Cancer Therapy: Clinical
    Increased Prevalence of Dihydropyrimidine Dehydrogenase Deficiency in African-Americans Compared with Caucasians
    Lori Kay Mattison, Jeanne Fourie, Renee A. Desmond, Anil Modak, Muhammad Wasif Saif and Robert B. Diasio
    Clin Cancer Res September 15 2006 12 (18) 5491-5495; DOI:10.1158/1078-0432.CCR-06-0747

  • Cancer Therapy: Clinical
    Pharmacogenetics of Capecitabine in Advanced Breast Cancer Patients
    Rémy Largillier, Marie-Christine Etienne-Grimaldi, Jean-Louis Formento, Joseph Ciccolini, Jean-François Nebbia, Aurélie Ginot, Mireille Francoual, Nicole Renée, Jean-Marc Ferrero, Cyril Foa, Moïse Namer, Bruno Lacarelle and Gérard Milano
    Clin Cancer Res September 15 2006 12 (18) 5496-5502; DOI:10.1158/1078-0432.CCR-06-0320

  • Cancer Therapy: Clinical
    Phase I Study of Abagovomab in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Paul Sabbatini, Jakob Dupont, Carol Aghajanian, Felicia Derosa, Elizabeth Poynor, Sybil Anderson, Martee Hensley, Phillip Livingston, Alexia Iasonos, David Spriggs, William McGuire, Silke Reinartz, Sally Schneider, Cathy Grande, Shashikant Lele, Kerry Rodabaugh, James Kepner, Soldano Ferrone and Kunle Odunsi
    Clin Cancer Res September 15 2006 12 (18) 5503-5510; DOI:10.1158/1078-0432.CCR-05-2670

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Adjuvanticity of Plasmid DNA Encoding Cytokines Fused to Immunoglobulin Fc Domains
    Cristina R. Ferrone, Miguel-Angel Perales, Stacie M. Goldberg, C. Joy Somberg, Daniel Hirschhorn-Cymerman, Polly D. Gregor, Mary Jo Turk, Teresa Ramirez-Montagut, Jason S. Gold, Alan N. Houghton and Jedd D. Wolchok
    Clin Cancer Res September 15 2006 12 (18) 5511-5519; DOI:10.1158/1078-0432.CCR-06-0979

  • Cancer Therapy: Preclinical
    Human Regulatory T Cells Control Xenogeneic Graft-versus-Host Disease Induced by Autologous T Cells in RAG2−/−γc−/− Immunodeficient Mice
    Tuna Mutis, Rozemarijn S. van Rijn, Elles R. Simonetti, Tineke Aarts-Riemens, Maarten E. Emmelot, Louis van Bloois, Anton Martens, Leo F. Verdonck and Saskia B. Ebeling
    Clin Cancer Res September 15 2006 12 (18) 5520-5525; DOI:10.1158/1078-0432.CCR-06-0035

  • Cancer Therapy: Preclinical
    The Thalidomide Analogue, CC-4047, Induces Apoptosis Signaling and Growth Arrest in Childhood Acute Lymphoblastic Leukemia Cells In vitro and In vivo
    Shabnam Shalapour, Andrea Zelmer, Madlen Pfau, Eva Moderegger, Cristiane Costa-Blechschmidt, Frank K.H. van Landeghem, Tillmann Taube, Iduna Fichtner, Christoph Bührer, Günter Henze, Karl Seeger and Sven Wellmann
    Clin Cancer Res September 15 2006 12 (18) 5526-5532; DOI:10.1158/1078-0432.CCR-06-0719

  • Cancer Therapy: Preclinical
    The Ras Inhibitor Farnesylthiosalicylic Acid as a Potential Therapy for Neurofibromatosis Type 1
    Batya Barkan, Sigal Starinsky, Eitan Friedman, Reuven Stein and Yoel Kloog
    Clin Cancer Res September 15 2006 12 (18) 5533-5542; DOI:10.1158/1078-0432.CCR-06-0792

  • Cancer Therapy: Preclinical
    In vivo Efficacy of STX213, A Second-Generation Steroid Sulfatase Inhibitor, for Hormone-Dependent Breast Cancer Therapy
    Paul A. Foster, Simon P. Newman, Surinder K. Chander, Chloe Stengel, Roma Jhalli, Lawrence L.W. Woo, Barry V.L. Potter, Michael J. Reed and Atul Purohit
    Clin Cancer Res September 15 2006 12 (18) 5543-5549; DOI:10.1158/1078-0432.CCR-06-0632

  • Cancer Therapy: Preclinical
    Human Neural Stem Cells Target Experimental Intracranial Medulloblastoma and Deliver a Therapeutic Gene Leading to Tumor Regression
    Seung-Ki Kim, Seung U. Kim, In Ho Park, Jung Hee Bang, Karen S. Aboody, Kyu-Chang Wang, Byung-Kyu Cho, Manho Kim, Lata G. Menon, Peter M. Black and Rona S. Carroll
    Clin Cancer Res September 15 2006 12 (18) 5550-5556; DOI:10.1158/1078-0432.CCR-05-2508

  • Cancer Therapy: Preclinical
    Benzethonium Chloride: A Novel Anticancer Agent Identified by Using a Cell-Based Small-Molecule Screen
    Kenneth W. Yip, Xinliang Mao, P.Y. Billie Au, David W. Hedley, Sue Chow, Shadi Dalili, Joseph D. Mocanu, Carlo Bastianutto, Aaron Schimmer and Fei-Fei Liu
    Clin Cancer Res September 15 2006 12 (18) 5557-5569; DOI:10.1158/1078-0432.CCR-06-0536

  • Cancer Therapy: Preclinical
    Antitumor Activity of Suberoylanilide Hydroxamic Acid against Thyroid Cancer Cell Lines In vitro and In vivo
    Quang T. Luong, James O'Kelly, Glenn D. Braunstein, Jerome M. Hershman and H. Phillip Koeffler
    Clin Cancer Res September 15 2006 12 (18) 5570-5577; DOI:10.1158/1078-0432.CCR-06-0367

  • Cancer Therapy: Preclinical
    Interleukin 6, a Nuclear Factor-κB Target, Predicts Resistance to Docetaxel in Hormone-Independent Prostate Cancer and Nuclear Factor-κB Inhibition by PS-1145 Enhances Docetaxel Antitumor Activity
    Josep Domingo-Domenech, Cristina Oliva, Ana Rovira, Jordi Codony-Servat, Marta Bosch, Xavier Filella, Clara Montagut, Marian Tapia, Clara Campás, Lenny Dang, Mark Rolfe, Jeffrey S. Ross, Pere Gascon, Joan Albanell and Begoña Mellado
    Clin Cancer Res September 15 2006 12 (18) 5578-5586; DOI:10.1158/1078-0432.CCR-05-2767

  • Cancer Therapy: Preclinical
    Bispecific Antibody Pretargeting of Tumor Neovasculature for Improved Systemic Radiotherapy of Solid Tumors
    Dieter Moosmayer, Dietmar Berndorff, Chien-Hsing Chang, Robert M. Sharkey, Axel Rother, Sandra Borkowski, Edmund A. Rossi, William J. McBride, Thomas M. Cardillo, David M. Goldenberg and Ludger M. Dinkelborg
    Clin Cancer Res September 15 2006 12 (18) 5587-5595; DOI:10.1158/1078-0432.CCR-06-0210

Cancer Susceptibility and Prevention

  • Cancer Susceptibility and Prevention
    Polymorphisms of FAS and FAS Ligand Genes Involved in the Death Pathway and Risk and Progression of Squamous Cell Carcinoma of the Head and Neck
    Zhengdong Zhang, Li-E Wang, Erich M. Sturgis, Adel K. El-Naggar, Waun K. Hong, Christopher I. Amos, Margaret R. Spitz and Qingyi Wei
    Clin Cancer Res September 15 2006 12 (18) 5596-5602; DOI:10.1158/1078-0432.CCR-05-1739

Letters to the Editor

  • Letters to the Editor
    Aromatase Inhibitors and Postmenopausal Breast Cancer Patients with Tamoxifen-Induced Endometrial Pathology
    Leilani Morales, Robert Paridaens, Dirk Timmerman and Patrick Neven
    Clin Cancer Res September 15 2006 12 (18) 5603-5603; DOI:10.1158/1078-0432.CCR-06-0897

Back to top
PreviousNext
Clinical Cancer Research: 12 (18)
September 2006
Volume 12, Issue 18
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author

Sign up for alerts

Issue Highlights

  • Prevalence of FOXP3+ Regulatory T Cells Increases During the Progression of Pancreatic Ductal Adenocarcinoma and Its Premalignant Lesions
  • Curcumin Inhibits Neurotensin-Mediated Interleukin-8 Production and Migration of HCT116 Human Colon Cancer Cells
  • EWS-CREB1: A Recurrent Variant Fusion in Clear Cell Sarcoma—Association with Gastrointestinal Location and Absence of Melanocytic Differentiation
  • In vitro Drug Sensitivity Predicts Response and Survival after Individualized Sensitivity-Directed Chemotherapy in Metastatic Melanoma: A Multicenter Phase II Trial of the Dermatologic Cooperative Oncology Group

Jump to

  • Editor's Note
  • Editorial
  • The Biology Behind
  • Molecular Pathways
  • CCR Focus
  • Report from the FDA
  • Review
  • Human Cancer Biology
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Cancer Therapy: Preclinical
  • Cancer Susceptibility and Prevention
  • Letters to the Editor
Advertisement
  • Most Cited
  • Most Read
Loading
  • Hyperprogressive Disease with Anti-PD-1/PD-L1 Therapy
  • Multiplex Genome Editing to Generate Universal CAR T Cells
  • Integrated Safety Analysis of Urelumab
  • Genomics of Immunotherapy-Associated Hyperprogressors
  • Translational Genomics in Breast Cancer
More...
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement